JESSICA SAENZ: Open Payments
NPI 1265763874 · SAN JUAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 33 payments from 17 companies in 2025. Trend: 2023 $1,496 · 2024 $1,459 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $194 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| PFIZER INC. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: BREZTRI, TRELEGY ELLIPTA, FARXIGA, JARDIANCE, Wegovy, NURTEC ODT, GARDASIL 9, ZORYVE.
Industry payments across TX — which companies pay providers there.
